2
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T35404 |
(±)13-HODE cholesteryl ester
|
||
(±)13-HODE cholesteryl ester was originally extracted from atherosclerotic lesions and shown to be produced by Cu2+-catalyzed oxidation of LDL. Later studies determined that 15-LO from rabbit reticulocytes and human monocytes were able to metabolize cholesteryl linoleate, a major component of LDL, to 13-HODE cholesteryl ester. | |||
T35405 |
(±)9-HODE cholesteryl ester
|
||
(±)9-HODE cholesteryl ester was originally extracted from atherosclerotic lesions and shown to be produced by Cu2+-catalyzed oxidation of LDL. Later studies determined that 15-LO from rabbit reticulocytes and human monocytes were able to metabolize cholesteryl linoleate, a major component of LDL, to 9-HODE cholesteryl ester. |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T5214 |
Cholesteryl linoleate
CE(18:2(9Z,12Z)),Cholesterol Linoleate,Linoleic Acid cholesteryl ester,胆甾烯基亚油酸酯 |
Others; Endogenous Metabolite | Metabolism; Others |
Cholesteryl linoleate (Linoleic Acid cholesteryl ester) 是低密度脂蛋白和动脉粥样硬化病变中主要的胆固醇酯。它存在于 LDL 中的胆固醇酯,利用 LDL 受体相关蛋白转移到表达 15-脂氧合酶的巨噬细胞和 CHO 细胞的质膜,被氧化形成胆固醇亚油酸氢过氧化物。 |